United States Securities and Exchange Commission
Division of Corporation Finance
Attn: Jimmy McNamara
100 F Street, N.E.
Washington, DC 20549
| Re: | Propanc Biopharma, Inc. | |
| Registration Statement on Form S-1 | ||
| Filed February 2, 2026 | ||
| File No. 333-293147 |
REQUEST FOR WITHDRAWAL OF ACCELERATION OF EFFECTIVENESS
Ladies and Gentlemen:
Reference is made to our letter, dated February 10, 2026 in which we requested acceleration of the effective date of the above referenced Registration Statement to February 12, 2026 at 9:30 a.m. Eastern Standard Time. We are no longer requesting that such Registration Statement be declared effective at such time, and we hereby formally, and with immediate effect, withdraw our request for acceleration of the effective date.
| Very truly yours, | ||
| Propanc Biopharma, Inc. | ||
| By: | /s/ James Nathanielsz | |
| Name: | James Nathanielsz | |
| Title: | Chief Operating Officer | |